How much does a box of the anti-cancer drug Osimertinib cost in 2024, and how much can it be reimbursed? How to buy?

Osimertinib, trade name Tagrisso, is a third-generation targeted drug for non-small cell lung cancer (NSCLC), especially for patients with EGFR mutation-positive patients. By specifically inhibiting the activity of EGFR mutant protein, it significantly inhibits the growth and spread of tumor cells, bringing new treatment prospects to many lung cancer patients. However, due to its high research and development costs, the market price of osimertinib in my country is also relatively high. A box of 80mg*30 tablets sells for about five to six thousand yuan, which is undoubtedly a considerable financial burden for many patients.

Fortunately, for patients who qualify for reimbursement, part of the cost of osimertinib can be mitigated through Medicare reimbursement. The specific reimbursement ratio varies according to different regions and medical insurance policies, but generally speaking, patients can enjoy certain cost reductions when purchasing. However, it should be noted that medical insurance reimbursement usually requires patients to meet certain indication conditions and be diagnosed and prescribed by a doctor.

In addition to the original drug, there are also some generic drugs of osimertinib on the market, among which the generic drugs produced by Lucius in Laos are very popular. These generic drugs are similar in efficacy to the original drugs, but are more affordable. A box of 80mg*30 tablets costs about five to six hundred yuan, which is only about one-tenth of the price of the original drugs. In addition, the prices of drugs of the same specifications produced by Laos United Pharmaceuticals and Laos ASEAN Pharmaceuticals are also relatively low, about six to seven hundred yuan. These generic drugs provide patients with more treatment options and financial relief.

When purchasing osimertinib, patients can do so through a variety of channels. First, patients can purchase original drugs at regular domestic hospitals or pharmacies and consult doctors about the specific procedures and conditions for medical insurance reimbursement. Secondly, for generic drugs, patients can purchase them through some legal overseas medical institutions. However, it should be noted that the price of overseas drugs may change due to factors such as exchange rates, so it is best to consult a professional to obtain the latest price information before purchasing.

In summary, osimertinib, as an important anticancer drug, provides patients with a new treatment option. However, its high price also prohibits many patients. Fortunately, health insurance reimbursement and the emergence of generic drugs have provided patients with more financial support and treatment options. When purchasing, patients should choose appropriate drugs and purchasing channels based on their actual situation and doctor’s recommendations.